Medacta Group SA (LON:0A05)
London · Delayed Price · Currency is GBP · Price in CHF 149.40
-0.66 (-0.44%)
At close: Oct 24, 2025
Medacta Group Market Cap
Medacta Group has a market cap or net worth of 2.81 billion as of October 24, 2025. Its market cap has increased by 28.23% in one year.
Market Cap
2.81B
Enterprise Value
3.01B
Revenue
553.81M
Ranking
n/a
PE Ratio
34.57
Stock Price
149.40
Market Cap Chart
Since April 4, 2019, Medacta Group's market cap has increased from 1.47B to 2.81B, an increase of 91.21%. That is a compound annual growth rate of 10.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 2.81B | 50.11% |
| Dec 30, 2024 | 1.87B | -19.82% |
| Dec 29, 2023 | 2.34B | 26.53% |
| Dec 30, 2022 | 1.85B | -19.74% |
| Dec 30, 2021 | 2.30B | 57.81% |
| Dec 30, 2020 | 1.46B | 28.09% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.78B |
| GSK plc | 66.45B |
| Haleon | 31.57B |
| Smith & Nephew | 11.83B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 3.94B |
| HUTCHMED (China) | 1.96B |
| Genus | 1.74B |